Equibles does not estimate personal net worth.
Get an email with a short summary when Metagenomi Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get MGX alertsJohn Irish is recorded as CEO at Metagenomi Therapeutics, Inc. (MGX). John Irish has spoken on 1 investor event across 1 company, most recently for Metagenomi Therapeutics, Inc. on October 20, 2026. Metagenomi Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Metagenomi Therapeutics, Inc. includes Jian Irish (CEO, COO and Board Member), Pamela Wapnick (CFO), Matthew L. Wein (General Counsel) and 6 others.
“So hemophilia A is probably a more familiar disease to us, so let's start with the patients. Despite the modern therapy, children with severe hemophilia today still grow up expecting joint damages from cumulative bleeding.”
Biotechnology · Healthcare
CEO
